Asians drinking alcohol

(Photo by cottonbro studio from Pexels)

Study warns that consistent heavy alcohol consumption across adulthood raises colorectal cancer risk by 91%

In A Nutshell

  • People who drank heavily throughout their adult lives had 91% higher colorectal cancer risk compared to consistent light drinkers, with rectal cancer risk nearly doubling among heavy lifetime drinkers.
  • Cancer location mattered: rectal cancer showed the strongest link to alcohol, distal colon cancer showed moderate associations, while proximal colon cancer showed no connection to drinking patterns.
  • Sustained heavy drinking across multiple life stages drove the cancer connection: those who drank heavily at some points but moderately at others showed no clear increase in risk.
  • Former drinkers had 42% lower odds of developing certain precancerous polyps, though the study can’t prove whether quitting caused the benefit or if people who quit simply differ in other health-related ways.

Most studies on alcohol and cancer ask people how much they currently drink. But what about beer drank in college? How about the wine with dinner that’s a habit for so many adults in their thirties? A 20-year study of nearly 90,000 Americans suggests those earlier drinking patterns matter just as much as current habits.

People who drank heavily throughout their adult lives faced sharply higher colorectal cancer risk, with the strongest effect on rectal cancer. Current drinkers averaging 14 or more drinks weekly over their lifetime had 95% higher rectal cancer risk compared to light drinkers, nearly doubling their rate during follow-up. For consistent heavy drinkers across multiple life stages, overall colorectal cancer risk jumped 91% compared with people who stayed light drinkers across adulthood.

The National Cancer Institute tracked 88,092 participants for up to two decades, during which 1,679 developed colorectal cancer. However, unlike most research, scientists asked detailed questions about drinking during four life stages: ages 18-24, 25-39, 40-54, and 55-plus.

Why Lifetime Drinking Patterns Beat Single Snapshots

Someone who reports moderate drinking at age 65 could have been a heavy drinker for decades before cutting back. Or they might have been light drinkers their whole lives. Traditional studies miss this entirely.

The researchers calculated average alcohol intake across each person’s adult life, weighing it by years at each drinking level. Current drinkers averaging 14 or more drinks per week over their lifetime had 25% higher colorectal cancer risk than those averaging less than one drink weekly.

Crucially people who drank heavily at multiple life stages faced a much higher cancer risk. Those who were heavy drinkers at some points but moderate at others didn’t show a clear increase in risk. Sustained heavy drinking over years appears to drive the cancer connection, not occasional heavy periods.

Friends getting drunk, funneling beer and alcohol at party
Heavy drinking is seen a rite of passage on countless college campuses – but alcohol’s health impact lingers long after intoxication fades. (© LIGHTFIELD STUDIOS – stock.adobe.com)

Cancer Location Matters More Than Expected

The type and location of cancer varied dramatically by drinking pattern. Rectal cancer showed the strongest link, with heavy lifetime drinkers facing 95% higher risk compared to light drinkers.

Cancers in the distal colon, the left side of the colon closer to the rectum, showed moderate associations with alcohol. But cancers in the proximal colon, the first section after the small intestine, showed no connection to drinking at all.

Why the difference? Researchers can’t answer that from this study alone, but one theory is that rectal tissue sits at the end of the digestive tract and may get more direct exposure to alcohol’s breakdown products. When the body processes alcohol, it creates acetaldehyde, which can damage cells.

What About People Who Quit Alcohol Entirely?

Former drinkers had 42% lower odds of developing certain precancerous polyps, specifically nonadvanced adenomas, compared to current light drinkers. This could hint that stopping helps. But it could also be that people who quit differ in other ways that independently affect cancer risk.

People quit drinking for many reasons, some health-related. The researchers checked whether underlying illness might explain the pattern by excluding anyone who developed cancer within two years of joining the study. The pattern still showed up, which makes it less likely that early, undiagnosed illness fully explains it. Still, the study can’t prove quitting was the reason.

The research, published in Cancer, also followed more than 12,000 people who had clear flexible sigmoidoscopy screenings at the start. Three to five years later, 812 had developed polyps. This tracking of polyp development over time adds evidence that alcohol affects early cancer processes, not just full-blown tumors.

The Confusing Middle Ground

People drinking seven to 14 drinks weekly over their lifetime had 21% lower colorectal cancer risk than those drinking less than one drink per week. This inverse pattern was strongest for distal colon cancer and appeared mainly in people who got screening.

Before anyone starts thinking moderate drinking prevents cancer, consider this: moderate drinkers in the study had higher education levels and different lifestyles than people who barely drank at all. Some near-abstainers may have health problems or past drinking issues that influenced their low consumption. The apparent benefit could easily reflect these unmeasured differences rather than any protective effect of alcohol itself.

How Alcohol Fuels Colorectal Cancer Growth

Alcohol breaks down into acetaldehyde in the liver, a compound that damages DNA and causes mutations in cells lining the colon and rectum. The International Agency for Research on Cancer classifies acetaldehyde as cancer-causing in humans.

Drinking also blocks folate absorption. Folate helps maintain the chemical tags on DNA that control which genes turn on and off. Without enough folate, these patterns go haywire. Colorectal tumors often show these abnormal patterns early, before cells even look cancerous under a microscope.

Recent discoveries about gut bacteria add another layer. Scientists suspect alcohol may shift the bacterial populations living in the intestines, changing how gut cells grow, die, and respond to the immune system. Some of these bacterial changes might trigger inflammation that helps tumors take root.

Friends toasting beer and alcohol at bar
Life-long heavy drinkers saw their overall colorectal cancer risk jump 91% compared to those who stayed light drinkers. (Photo by Fred Moon on Unsplash)

Reading Between the Lines

Half the study participants received screening with flexible sigmoidoscopy while the other half got usual care. This split let researchers separate screening effects from drinking effects. People reported their drinking patterns before cancer developed, so a cancer diagnosis wasn’t shaping their answers, though memory of drinking decades earlier is imperfect.

The study population skewed white, educated, and healthier than average Americans. Results may not apply equally across all groups. With 247 rectal cancers, 390 distal colon cancers, and 1,004 proximal colon cancers, the numbers were solid for overall findings but thinner when splitting by cancer location.

Also, people tend to underreport how much they drink. But since everyone reported before diagnosis, any underreporting would affect all groups similarly rather than skewing results in one direction.

Colorectal cancer rates are climbing in Americans under 55 even as they drop in older adults who get screened. The U.S. Surgeon General recently flagged alcohol as a leading preventable cancer cause, noting that most Americans still don’t realize drinking raises cancer risk at all.


Disclaimer: This article is for informational purposes only and does not constitute medical advice. The research discussed examined associations between lifetime alcohol consumption patterns and colorectal cancer risk but cannot prove that alcohol directly causes cancer in individuals or that reducing alcohol intake will prevent cancer. If you have concerns about your drinking habits or cancer risk, consult with a qualified healthcare provider who can evaluate your personal health history and circumstances.


Paper Summary

Limitations

The study participants were predominantly non-Hispanic white, generally healthier, and more educated than typical Americans, which may limit how broadly these results apply to other populations. The number of rectal and distal colon cancer cases was relatively small when breaking down results by specific cancer locations, limiting statistical confidence in those comparisons. People self-reported their alcohol intake, which typically leads to some underreporting, though this likely affected all groups equally given the study’s forward-looking design. Testing multiple associations increases the chance of finding patterns by coincidence. Despite adjusting for many factors, unmeasured differences like detailed socioeconomic status could still explain some findings. The study cannot definitively prove whether quitting drinking reduces cancer risk or whether people who quit differ from continuing drinkers in ways that independently affect cancer development.

Funding and Disclosures

This research received support from the Intramural Research Program of the National Institutes of Health, National Cancer Institute (grants K07 CA230182 and 3K07CA230182-05S1 to Dr. Barry), and the Maryland Department of Health’s Cigarette Restitution Fund Program (grant CH-649-CRF). The authors reported no conflicts of interest. Multiple state cancer registries provided cancer diagnosis data, with support from the Centers for Disease Control and Prevention’s National Program for Central Registries, individual states, or the National Cancer Institute’s Surveillance, Epidemiology, and End Results program.

Publication Details

The study “Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial” was authored by Caitlin P. O’Connell (Division of Cancer Epidemiology and Genetics, Metabolic Epidemiology Branch, National Cancer Institute), Sonja I. Berndt (Division of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute), Kenechukwu Chudy-Onwugaje (Center for Global Health, Perelman School of Medicine, University of Pennsylvania), Andrew Kunzmann (Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast), Wen-Yi Huang (Division of Cancer Epidemiology and Genetics, Metabolic Epidemiology Branch, National Cancer Institute), Kathryn Hughes Barry (Department of Epidemiology and Public Health, University of Maryland School of Medicine), and Erikka Loftfield (Division of Cancer Epidemiology and Genetics, Metabolic Epidemiology Branch, National Cancer Institute). The paper was published in Cancer on January 26, 2026, DOI: 10.1002/cncr.70201. The manuscript was received May 16, 2025, revised November 3, 2025, and accepted November 4, 2025.

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Reply